Spyre Therapeutics (SYRE) Selling, General & Administrative (2015 - 2026)
Spyre Therapeutics (SYRE) recorded Selling, General & Administrative of $16.14 million in Q2 2026, up 36.9% from $11.79 million a year earlier and up 5.9% from the prior quarter.
Powered by 
Analysis
Spyre Therapeutics (SYRE) Selling, General & Administrative (2015 - 2026) Analysis & Trends
On a TTM basis, Spyre Therapeutics' Selling, General & Administrative came in at $55.54 million as of Jun 30, 2026, up 23.0% year-over-year; for FY2025, it came in at $47.91 million, up 4.7% from FY2024.
- Annual Selling, General & Administrative has increased for 11 straight years, with a five-year compound annual growth rate of 17.0% (FY2020 to FY2025).
- Across earlier years, Selling, General & Administrative came in at $45.78 million in FY2024 (+14.6%), $39.95 million in FY2023 (+40.0%), $28.53 million in FY2022 (+4.4%) and $27.32 million in FY2021 (+25.1%).
- The Q2 2026 figure is the highest quarterly Selling, General & Administrative in data going back to Q1 2015.
- On a year-over-year basis, Selling, General & Administrative has increased for five consecutive quarters, with growth averaging 10.8% over the last eight quarters.
- Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 177.1% in Q4 2023, against a decline of 40.8% in Q1 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $15.23 million (Q1 2026), $12.53 million (Q4 2025) and $11.64 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Spyre Therapeutics | 8.21 Bn | 8.21 Bn | - | 16.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.14 Mn |
| Mar 31, 2026 | 15.23 Mn |
| Dec 31, 2025 | 12.53 Mn |
| Sep 30, 2025 | 11.64 Mn |
| Jun 30, 2025 | 11.79 Mn |
| Mar 31, 2025 | 11.94 Mn |
| Dec 31, 2024 | 10.77 Mn |
| Sep 30, 2024 | 10.65 Mn |
| Jun 30, 2024 | 11.51 Mn |
| Mar 31, 2024 | 12.85 Mn |
| Dec 31, 2023 | 14.07 Mn |
| Sep 30, 2023 | 8.58 Mn |
| Jun 30, 2023 | 12.06 Mn |
| Mar 31, 2023 | 5.23 Mn |
| Dec 31, 2022 | 5.08 Mn |
| Sep 30, 2022 | 6.95 Mn |
| Jun 30, 2022 | 7.68 Mn |
| Mar 31, 2022 | 8.83 Mn |
| Dec 31, 2021 | 7.30 Mn |
| Sep 30, 2021 | 6.84 Mn |
API Access
Spyre Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=SYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "SYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=SYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();